LCA-Vision Inc.  

(Public, NASDAQ:LCAV)   Watch this stock  
Find more results for LCAV
3.11
-0.03 (-0.96%)
May 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 3.11 - 3.18
52 week 2.67 - 6.19
Open 3.15
Vol / Avg. 13,735.00/44,641.00
Mkt cap 59.67M
P/E     -
Div/yield     -
EPS -0.59
Shares 19.19M
Beta 3.07
Inst. own 55%
Jul 29, 2013
Q2 2013 LCA-Vision Earnings Release Add to calendar
May 21, 2013
LCA-Vision Annual Shareholder Meeting
Apr 30, 2013
Q1 2013 LCA-Vision Earnings Conference Call - Webcast
Apr 22, 2013
Q1 2013 LCA-Vision Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 4.26% -8.39%
Operating margin 3.61% -9.18%
EBITD margin - -3.02%
Return on average assets 9.76% -14.76%
Return on average equity 23.68% -36.98%
Employees 335 -
Carbon Disclosure Rating - -

Address

7840 Montgomery Road
CINCINNATI, OH 45236
United States - Map
+1-513-7929292 (Phone)
+1-513-7925620 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.

Officers and directors

Michael J. Celebrezze Chief Executive Officer
Bio & Compensation  - Reuters
Amy F. Kappen Chief Financial Officer
Age: 41
Bio & Compensation  - Reuters
Bharat Kakar Senior Vice President - Operations and Marketing
Age: 44
Bio & Compensation  - Reuters
Rhonda S. Sebastian Senior Vice President - Human Resources
Age: 58
Bio & Compensation  - Reuters
E. Anthony Woods Non-Executive Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
James C Wachtman Director
Age: 47
Bio & Compensation  - Reuters
William F. Bahl Independent Director
Age: 61
Bio & Compensation  - Reuters
John H. Gutfreund Independent Director
Age: 82
Bio & Compensation  - Reuters
John C. Hassan Independent Director
Age: 69
Bio & Compensation  - Reuters